Second trimester maternal dimeric inhibin-A in the multiple-marker screening test for Down's syndrome

Human Reproduction

Volumn 13, Issue 3, 1998, Pages 744-748

  Renier, Martin A ^a   Vereecken, Annie ^b   Van Herck, Erik ^b   Straetmans, Danny ^b   Ramaekers, Paul ^b   Buytaert, Philippe ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Laboratory of Clinical Biology   (Belgium)

Author keywords

Dimeric inhibin A; Down's syndrome; Screening; Second trimester

Indexed keywords

ALPHA FETOPROTEIN; DIMER; ESTRIOL; INHIBIN A;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN SYNDROME; ESTRIOL BLOOD LEVEL; FEMALE; HUMAN; INTERMETHOD COMPARISON; NORMAL HUMAN; PRENATAL DIAGNOSIS; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SMOKING; TRISOMY 21;

EID: 0031944759     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.3.744     Document Type: Article

References (27)

1. Aitken, D.A., Wallace, E.M., Crossley, J.A. et al. (1996) Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N. Engl. J. Med., 334, 1231-1236.
2. Brambati, B., MacIntosh, M.C.M., Teisner, B. et al. (1993) Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br. J. Obstet. Gynaecol., 100, 324-326.
3. Brock, D.J.H., Barron, L., Holloway, S. et al. (1990) First trimester maternal serum biochemical indicators in Down's syndrome. Prenat. Diagn., 10, 245-251.
4. Cheng, E.Y., Luthy, D.A., Zebelman, A.M. et al. (1993) A prospective evaluation of a second-trimester screening test for fetal Down's syndrome using maternal serum α-fetoprotein, hCG, and unconjugated estriol. Obstet. Gynecol, 81, 12-11.
5. Cuckle, H.S., Wald, N.J. and Thompson, S. (1987) Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum α-fetoprotein level. Br. J. Obstet. Gynaecol., 94, 387-402.
6. Cuckle, H.S., Wald, H.J. and Densem, J.W. (1992) The effect of smoking in pregnancy on maternal serum α-foetoprotein, unconjugated estriol, HCG, progesterone and DHEA-sulphate levels, Br. J. Obstet. Gynaecol., 92, 272.
7. Cuckle, H.S., Holding, S. and Jones, R. (1994a) Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies. Prenat. Diagn., 14, 387-390.
8. Cuckle, H., van Oudgaarden, E.D., Mason, G. et al. (1994b) Taking account of vaginal bleeding in screening for Down's syndrome. Br. J. Obstet. Gynaecol., 101, 948-953.
9. Cuckle, H.S., Holding, S., Jones, R. et al. (1995) Maternal serum dimeric inhibin A in second trimester Down's syndrome pregnancies. Prenat. Diagn., 15, 385-386.
10. Cuckle, H. (1996) Evaluation of screening programmes. Baillières Clin. Obstet. Gynecol., 10, 631-645.
11. Haddow, J.E., Palomaki, G.E., Knight, G.J. et al. (1992) Prenatal screening for Down's syndrome with use of maternal serum markers. N. Engl. J. Med., 327, 588-593.
12. Heinonen, S., Ryynänen, M., Kirkinem, P. et al. (1996) Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil. Steril., 66, 398-403.
13. Ind, T.E., Iles, R.K., Wathen, N.C. et al. (1993) Low levels of amniotic fluid placental alkaline phosphatase in Down's syndrome. Br. J. Obstet. Gynaecol., 100, 847-849.
14. Kratzer, P.G., Golbus, M.S., Monroe, S.E. et al (1991) First-trimester aneuploidy screening using serum human chorionic gonadotrophin (hCG), free αhCG, and progesterone. Prenat. Diagn., 11, 751-765.
15. Merkatz, I.R., Nitowsky, H.M. and Macri, J.N. (1984) An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities. Am. J. Obstet. Gynecol., 148, 886-894.
16. Mooney, R.A., Arvan, D.A., Salier, D.N. et al. (1995) Decreased maternal serum hCG levels with increasing gravidity and parity. Obstet, Gynecol., 86, 900-905.
17. Muttukrishna, S., Knight, P.G., Groome, N.R et al. (1997) Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet, 349, 1285-1288.
18. Palomaki, G.E., Knight, G.J., Haddow, J.E. et al. (1992) Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum α-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat. Diagn., 12, 925-930.
19. Petraglia, F., Sawchenko, P., Lim, A.T. et al. (1987) Localization, secretion, and action of inhibin in human placenta. Science, 237, 187-189.
20. Ribbert, L.S.M., Komman, L.H., De Wolf, B.T.H. et al. (1996) Maternal serum screening for fetal Down's syndrome in IVF pregnancies. Prenat. Diagn., 16, 35-38.
21. Riley, S.C., Wathen, N.C., Chard, T. et al. (1996) Inhibin in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum. Reprod., 11, 2772-2776.
22. Spencer, K., Wood, P.J. and Anthony, F.W. (1993) Elevated levels of maternal serum inhibin immunere activity in second trimester pregnancies affected by Down's syndrome. Ann. Clin. Biochem., 30, 219-220.
23. Van Lith, J.M.M., Pratt, J.J., Beekhuis, J.R. et al. (1992) Second trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat. Diagn., 12, 801-806.
24. Wald, N.J. (1991) Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome. Br. J. Obstet. Gynaecol., 98, 905-909.
25. Wald, N.J., Densem, J.W. and George, L. (1997) Inhibin-A in Down's syndrome pregnancies: revised estimate of standard deviation. Prenat. Diagn., 17, 285-290.
26. Wallace, E.M., Grant, V.E., Swanston, I.A. et al. (1995) Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome. Prenat. Diagn., 15, 359-362.
27. Wallace, E.M., Swanston, I.A., McNeilly, A.S. et al. (1996) Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin. Endocrinol., 44, 17-21.